Condition (MeSH)
Echinococcosis
ClinicalTrials.gov lists 35 trials for Echinococcosis or a narrower condition beneath it. National Institute of Allergy and Infectious Diseases (NIAID) has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
24 of the 35 trials are tagged with Echinococcosis itself; the rest are tagged with a narrower condition beneath it.
When did Echinococcosis trials start? (19)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Not applicable
- Observational
Top of scale: 5
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 1 |
| 2024 | 3 |
| 2023 | 5 |
| 2022 | 1 |
| 2021 | 5 |
| 2020 | 1 |
| 2018 | 2 |
| 2017 | 2 |
| 2016 | 1 |
Showing 10 of 19 earlier years.
No forecast is made for this condition: it averages 2.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 35 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Echinococcosis trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Not applicable | 10 |
| Observational | 23 |
How many Echinococcosis trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 5 |
| Completed | 22 |
| Terminated | 1 |
| Unknown status | 6 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Echinococcosis trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Dr. Ersin Arslan Education and Training Hospital | 1 |
Which drugs are being tested for Echinococcosis? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Benzimidazole | 1 |
| Albendazole | 1 |
Interventions as named in the registry (3)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Efficacy of albendazole for early stage intervention of alveolar echinococcosis | 1 |
| TREATMENT | 1 |
| Blood sample for multiplex QPCR technique | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Echinococcosis? (17)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Ultrasound identification of hepatic echinococcosis using a deep convolutional neural network model in China: a retrospective, large-scale, multicentre, diagnostic accuracy study. | The Lancet. Digital health | 2023 | Yes |
| Detection and subtyping of hepatic echinococcosis from plain CT images with deep learning: a retrospective, multicentre study. | The Lancet. Digital health | 2023 | Yes |
| Echinococcosis: a Challenge for Liver Sonography. | Ultraschall in der Medizin (Stuttgart, Germany : 1980) | 2022 | Yes |
| Jaundice as a clinical presentation in liver hydatidosis increases the risk of postoperative biliary fistula. | Langenbeck's archives of surgery | 2021 | Yes |
| Albendazole and Treatment of Hydatid Cyst: Review of the Literature. | Infectious disorders drug targets | 2019 | Yes |
Showing 5 of 17 publications.
Prevalence (4)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Cystic echinococcosis | Annual incidence | 1-9 / 100 000 | Europe | Not stated | Exact |
| Cystic echinococcosis | Annual incidence | 1-9 / 100 000 | Europe | Not stated | Exact |
| Cystic echinococcosis | Point prevalence | Unknown | Worldwide | Not stated | Exact |
| Cystic echinococcosis | Point prevalence | Unknown | Worldwide | Not stated | Exact |
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Cystic echinococcosis | 400 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Cystic echinococcosis | 400 | Exact | Orphadata Science knowledge files, Product 1 |
Sub-conditions in MeSH (2)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials.